Name | desvaleroyl valsartan |
---|---|
Synonyms |
N-[[2'-(1H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl]methyl]-L-valine
(S)-2-(((2'-(2H-Tetrazol-5-yl)-[1,1'-biphenyl]-4-yl)methyl)amino)-3-methylbutanoic acid (S)-3-methyl-2-((2'-(1H-tetrazol-5-yl)biphenyl-4-ylmethyl)amino)butyric acid (S)-3-methyl-2-((2'-(1H-tetrazol-5-yl)-biphenyl-4-ylmethyl)-amino)-butyric acid N-{[2'-(2H-Tetrazol-5-yl)-4-biphenylyl]methyl}-L-valine L-Valine, N-[[2'-(2H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl]methyl]- (S)-2-(((2'-(1H-tetrazol-5-yl)-[1,1'-biphenyl]-4-yl)methyl)amino)-3-methylbutanoic acid Valsartan Impurity 11 |
Description | Devaleryl Valsartan Impurity is an intermediate in the synthesis of Valsartan[1]. |
---|---|
Related Catalog | |
References |
Density | 1.3±0.1 g/cm3 |
---|---|
Boiling Point | 598.2±60.0 °C at 760 mmHg |
Molecular Formula | C19H21N5O2 |
Molecular Weight | 351.402 |
Flash Point | 315.6±32.9 °C |
Exact Mass | 351.169525 |
PSA | 103.79000 |
LogP | 3.52 |
Vapour Pressure | 0.0±1.8 mmHg at 25°C |
Index of Refraction | 1.609 |
Precursor 0 | |
---|---|
DownStream 1 | |